Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioxcel Therapeutics Inc.

3.37
+0.630022.99%
Post-market: 3.19-0.1796-5.33%19:59 EST
Volume:2.51M
Turnover:7.85M
Market Cap:11.44M
PE:-0.11
High:3.44
Open:2.75
Low:2.68
Close:2.74
Loading ...

BioXcel Therapeutics Climbs After Enrollment Update in Drug Trial

Dow Jones
·
08 Mar

BioXcel Therapeutics Inc expected to post a loss of $6.38 a share - Earnings Preview

Reuters
·
07 Mar

BioXcel Therapeutics announces 33% enrollment in SERENTIY at-home Phase 3 trial

TIPRANKS
·
07 Mar

BioXcel Therapeutics: Serenity Phase 3 Safety Trial Topline Data Expected in H2 2025

THOMSON REUTERS
·
07 Mar

BioXcel Therapeutics Announces 33% Enrollment in Serenity at-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated With Bipolar Disorders or Schizophrenia

THOMSON REUTERS
·
07 Mar

ScPharmaceuticals, Inc. (SCPH) Expected to Beat Earnings Estimates: Should You Buy?

Zacks
·
05 Mar

BRIEF-Bioxcel Therapeutics Announces Closing Of $14 Million Registered Direct Offering

Reuters
·
05 Mar

BioXcel Therapeutics Announces Closing of $14 Million Registered Direct Offering

THOMSON REUTERS
·
05 Mar

BioXcel Therapeutics, Inc. (BTAI) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Zacks
·
04 Mar

BioXcel Therapeutics Announces $14 Million Registered Direct Offering

THOMSON REUTERS
·
04 Mar

Press Release: BioXcel Therapeutics Announces $14 Million Registered Direct Offering

Dow Jones
·
04 Mar

Top Midday Gainers

MT Newswires Live
·
04 Mar

BioXcel Therapeutics Inc - FDA Designates 'Voluntary Action Indicated' for Tranquility Ii Site

THOMSON REUTERS
·
03 Mar

BioXcel Therapeutics Inc - Believes FDA Report Supports Tranquility Ii Data Reliability

THOMSON REUTERS
·
03 Mar

BioXcel Therapeutics Announces FDA Closed Its Inspection of Site for Phase 3 Tranquility Ii Trial for Acute Treatment of Agitation Associated With Alzheimer’s Dementia

THOMSON REUTERS
·
03 Mar

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires Live
·
01 Mar